Klivira
Request demo

Streamlining Urology eviCore Integration for Advanced Care

Achieving seamless urology eviCore integration is critical for managing prior authorizations related to advanced imaging and specialized procedures in urologic care.

Revenue cycle leaders and prior authorization teams in urology practices face unique challenges when navigating eviCore's benefit management processes. From high-cost prostate cancer therapeutics to complex diagnostic imaging, ensuring timely approvals requires a precise understanding of payer requirements and efficient workflow automation.

The Intersection of Urology Prior Authorization and eviCore Management

Urology practices frequently encounter eviCore Healthcare for prior authorization of diagnostic imaging and certain interventional procedures. While eviCore is primarily known for radiology benefit management, its scope can extend to high-cost urologic imaging such as multiparametric prostate MRI and PSMA PET scans, which are crucial for prostate cancer staging and recurrence monitoring.

Common Urology Services Managed by eviCore

  • Multiparametric prostate MRI for cancer detection and staging.
  • PSMA PET imaging (e.g., Gallium-68 PSMA, Pylarify) for prostate cancer staging and biochemical recurrence.
  • CT Urograms for stone disease or hematuria evaluation.
  • Advanced diagnostic imaging related to BPH or OAB workups.

Navigating eviCore's Clinical Criteria for Urologic Care

eviCore's clinical review process for urologic services often aligns with established guidelines from bodies like the American Urological Association (AUA) and the National Comprehensive Cancer Network (NCCN). For prostate cancer imaging, this includes documentation of Gleason score, PSA levels, prior treatments, and NCCN-compendium-supported indications, particularly for PSMA imaging.

Essential Documentation for eviCore Urology Authorizations

  • Detailed clinical notes supporting medical necessity for advanced imaging.
  • Relevant laboratory results (e.g., PSA trends, creatinine).
  • Pathology reports (e.g., Gleason score for prostate cancer).
  • Prior treatment history, especially for prostate cancer therapeutics or BPH interventions.
  • Imaging reports from previous studies.

Optimizing Workflow for Urology eviCore Integration

The urgency of prostate cancer treatment initiation and the high volume of specialty drug authorizations in urology demand an efficient workflow for eviCore submissions. Challenges include ensuring complete documentation for imaging-vendor routing and minimizing delays that can impact patient care pathways.

Klivira's Role in Streamlining Urology eviCore Integration

Klivira's platform automates the prior authorization process, integrating directly with EMRs to extract necessary clinical data for eviCore submissions. Our system is designed with AUA/NCCN-guideline-aware policy logic to streamline authorizations for imaging like PSMA PET and multiparametric prostate MRI, reducing manual effort and improving turnaround times.

Benefits of Klivira for Urology eviCore PA

  • Automated data extraction for imaging orders from EMRs.
  • Pre-population of eviCore forms with relevant patient and clinical data.
  • Real-time status tracking for eviCore submissions.
  • Reduction in manual review and submission errors for complex urologic imaging.
  • Improved adherence to payer-specific clinical criteria for advanced diagnostics.

Frequently asked questions

Which urology services commonly require eviCore prior authorization?

In urology, eviCore often manages prior authorizations for advanced diagnostic imaging, particularly multiparametric prostate MRI and PSMA PET scans used for prostate cancer staging and recurrence. While eviCore primarily focuses on radiology, these high-cost imaging modalities fall within their benefit management scope.

How does Klivira handle the specific documentation requirements for eviCore urology PAs?

Klivira's platform integrates with your EMR to automatically extract critical clinical data, such as PSA levels, Gleason scores, and prior treatment history, which are often required by eviCore for urologic imaging and procedures. Our system leverages AUA and NCCN guideline logic to ensure comprehensive submissions.

Can Klivira help with urgent prior authorizations for prostate cancer patients undergoing eviCore review?

Yes, Klivira's automation is designed to accelerate the prior authorization workflow, which is crucial for urgent cases like prostate cancer treatment initiation or diagnostic imaging. By reducing manual steps and improving submission accuracy, we aim to minimize delays in eviCore's review process.

Does eviCore manage prior authorizations for urology specialty drugs?

eviCore primarily focuses on radiology and certain other benefit management categories. While they manage imaging related to prostate cancer, prior authorization for specialty drugs like oral androgen-receptor inhibitors or PSMA-targeted radiopharmaceuticals typically falls under pharmacy benefit managers (PBMs) or other medical benefit managers, not eviCore directly. This distinction is important for workflow routing.

What are common reasons for eviCore denials in urology?

Common denial reasons from eviCore in urology often relate to insufficient documentation of medical necessity for advanced imaging, lack of adherence to specific clinical criteria (e.g., NCCN guidelines for PSMA imaging), or incomplete submission data. Klivira helps mitigate these by ensuring robust and accurate data submission.

Related coverage

Other urology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo